Dark

RGC
Regencell Bioscience Holdings Limited
stock NASDAQ

At Close

Aug 3, 2026 3:58:45 PM EDT

6.12USD-0.971%(-0.06)292,182

0.00Bid 0.00Ask 0.00Spread

Pre-market

Aug 3, 2026 9:26:30 AM EDT

6.16USD-0.324%(-0.02)987

After-hours

Aug 3, 2026 4:58:30 PM EDT

6.30USD+2.941%(+0.18)18,160

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

3.07B

Headquarters

TN, USA

Industry

Drug Manufacturers-Specialty & Generic

Next Earnings

Oct 28, 2026 (85d)

Last Split

Jun 16, 202538for1

RDI MCS CNK AMC

RGC Stats

Avg. Vol. 10 Day

224,422

Avg. Vol. 30 Day

475,619

Employees

26,000

Market Cap

3,070,776,119

Shares Out.

494,488,908

On/Off Exchange

52%/48%

6 Month Beta

0.78

1 Year Beta

1.45

2 Year Beta

0.09

3 Year Beta

0.17

52 Week Low

4.51

52 Week High

69.00

SMA50

12.70

SMA200

21.12

1 Week

+6.52%

1 Month

-2.51%

3 Month

-77.30%

6 Month

-78.17%

1 Year

-54.87%

2 Year

+3,005.00%

5 Year

+2,522.47%

Profile

we are an early-stage bioscience company that focuses on research, development and commercialization of tcm for the treatment of neurocognitive disorders and degeneration, specifically attention deficit hyperactivity disorder ("adhd"), autism spectrum disorder ("asd") in infectious diseases such as covid-19. our goal is to improve the lives of adhd, asd and covid patients, their families and caregivers and become a market leader for the best tcm treatment globally.

RGC Stock Summary

Regencell Bioscience Holdings Limited (NASDAQ:RGC) stock price today is $6.12, and today's volume is 292,182. RGC is down -0.971% today. The 30 day average volume is 475,619. RGC market cap is 3.07B with 494,488,908 shares outstanding.